CLMB Relative Valuation
CLMB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLMB is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for CLMB's competitors is 0.99, providing a benchmark for relative valuation. Climb Global Solutions Inc Corp (CLMB) exhibits a P/S ratio of 0.90, which is -9.26% above the industry average. Given its robust revenue growth of 49.36%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
DNTH
Dianthus Therapeutics Inc
19.110
USD
-0.83%
OPT
Opthea Ltd
0
USD
+6.74%
RGR
Sturm Ruger & Company Inc
36.540
USD
-0.65%
CTO
CTO Realty Growth Inc
18.230
USD
-1.03%
CCRN
Cross Country Healthcare Inc
13.790
USD
-1.08%
WEST
Westrock Coffee Co
7.590
USD
+0.93%
AUTL
Autolus Therapeutics PLC
1.530
USD
+3.38%
CGEM
Cullinan Oncology Inc
7.900
USD
+2.46%
KRT
Karat Packaging Inc
31.080
USD
-1.18%
CTLP
Cantaloupe Inc
8.480
USD
+2.29%
FAQ
Is Climb Global Solutions Inc (CLMB) currently overvalued or undervalued?
Climb Global Solutions Inc (CLMB) is now in the Overvalued zone, suggesting that its current forward PE ratio of 20.22 is considered Overvalued compared with the five-year average of 11.99. The fair price of Climb Global Solutions Inc (CLMB) is between 19.85 to 102.35 according to relative valuation methord. Compared to the current price of 108.98 USD , Climb Global Solutions Inc is Overvalued By 6.48% .
What is Climb Global Solutions Inc (CLMB) fair value?
How does CLMB's valuation metrics compare to the industry average?
What is the current P/B ratio for Climb Global Solutions Inc (CLMB) as of May 21 2025?
What is the current FCF Yield for Climb Global Solutions Inc (CLMB) as of May 21 2025?
What is the current Forward P/E ratio for Climb Global Solutions Inc (CLMB) as of May 21 2025?